Mannkind Estimates Offering Price

Valencia-based MannKind has estimated an offering price between $13.00 and $15.00 per share in an IPO filing with the SEC. The offering, for 5.5M shares of stock, is expected to raise up to $94.8M for the company. MannKind develops therapeutic products for diabetes, cancer, inflammatory and autoimmune diseases. The company is headed by billionaire Alfred Mann. The IPO is being underwritten by UBS, Piper Jaffray, Wachovia, Jeffries & Co, and Harris Nesbitt. More information »